Can-Fite BioPharma Ltd. Operating Lease, Right-of-Use Asset, Amortization Expense
Can-Fite BioPharma Ltd. (CANF) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $42.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-03-26
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|
| 2025-12-31 | $42.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $20.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $37.00K 20-F · filed 2026-03-26 | |
| 2024-06-30 | $23.00K 6-K · filed 2025-08-28 | |
| 2023-12-31 | $94.00K 20-F · filed 2026-03-26 | |
| 2023-06-30 | $28.00K 6-K · filed 2024-08-29 | |
| 2022-12-31 | $54.00K 20-F · filed 2025-04-14 | |
| 2022-06-30 | $27.00K 6-K · filed 2023-08-31 | |
| 2021-12-31 | $55.00K 20-F · filed 2024-03-28 |